Form 4 filings across 4 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 8 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 16 most recent Form 4 transactions.
| Sep 23 | TBPH | Theravance Biopharma, Inc. | DTOISS◆ | 23,576 | — | — | — | Open the original filing on SEC.gov |
| Sep 23 | TBPH | Theravance Biopharma, Inc. | DTOISS◆ | 22,044 | — | — | — | Open the original filing on SEC.gov |
| Sep 23 | TBPH | Theravance Biopharma, Inc. | DTOISS◆ | 32,666 | — | — | — | Open the original filing on SEC.gov |
| Sep 23 | TBPH | Theravance Biopharma, Inc. | DTOISS | 6,009 | — | — | -100.0% | Open the original filing on SEC.gov |
| Sep 23 | TBPH | Theravance Biopharma, Inc. | DTOISS | 42,137 | — | — | -87.5% | Open the original filing on SEC.gov |
| Jun 17 | FDMT | 4D Molecular Therapeutics,… | AGRANT◆ | 50,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 12 | TBPH | Theravance Biopharma, Inc. | AGRANT◆ | 13,398 | — | — | — | Open the original filing on SEC.gov |
| Jun 12 | TBPH | Theravance Biopharma, Inc. | AGRANT | 6,009 | — | — | +14.3% | Open the original filing on SEC.gov |
| May 26 | MRVI | Maravai Lifesciences… | AGRANT | 46,293 | — | — | +27.3% | Open the original filing on SEC.gov |
| Apr 27 | ANAB | Anaptysbio, INC | AGRANT◆ | 11,250 | — | — | — | Open the original filing on SEC.gov |
| Jun 17, 2025 | FDMT | 4D Molecular Therapeutics,… | AGRANT◆ | 22,500 | — | — | — | Open the original filing on SEC.gov |
| Jun 16, 2025 | MRVI | Maravai Lifesciences… | AGRANT | 89,139 | $2.16 | $192.5K | +110.4% | Open the original filing on SEC.gov |
| May 19, 2025 | TBPH | Theravance Biopharma, Inc. | AGRANT◆ | 24,258 | — | — | — | Open the original filing on SEC.gov |
| May 19, 2025 | TBPH | Theravance Biopharma, Inc. | AGRANT | 10,649 | — | — | +33.8% | Open the original filing on SEC.gov |